Accelerate Your Early-Stage Product
The Station 41 Accelerator provides non-dilutive funding to advance new drug, biologic, or diagnostic products.
Station 41 Accelerator provides financial and technical support for Southern Research to partner with PIs at academic institutions to develop IP or tangible assets with commercial potential. Upon entry into the Accelerator platform, selected programs will work with technical experts and non-dilutive funding consultants to identify three milestones culminating in a Phase 1 SBIR / STTR equivalent package, an NIH Technology Readiness Level of 4, or a similarly rigorous development milestone.
The Accelerator builds on the successes of the Alabama Drug Discovery Alliance, which provides $1.4 million per year to support novel drug discovery programs.
Have you already formed a company for your product? Consider applying for the Therapeutics Development Fund.
Southern Research has launched the Therapeutics Development Fund to provide in-kind technical and entrepreneurial support to participating companies and innovators. In exchange, the program will incentivize participating companies to remain in the State of Alabama for five years.
Contact Us
"*" indicates required fields